Bolivia (Plurinational State of)
Tuberculosis profile
Population  2012 10 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 2.2 (0.93–3.9) 21 (8.8–37)
Mortality (HIV+TB only) 0.14 (0.12–0.18) 1.4 (1.2–1.7)
Prevalence  (includes HIV+TB) 23 (11–38) 215 (107–360)
Incidence  (includes HIV+TB) 13 (11–16) 127 (105–151)
Incidence (HIV+TB only) 0.43 (0.36–0.52) 4.1 (3.4–4.9)
Case detection, all forms (%) 62 (52–75)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 5 568 (71) Relapse 446 (66)
Smear-negative 571 (7) Treatment after failure 14 (2)
Smear-unknown / not done 0 (0) Treatment after default 86 (13)
Extrapulmonary 1 672 (21) Other 127 (19)
Other 0 (0)      
Total new 7 811   Total retreatment 673  
           
Other (history unknown) 0        
Total new and relapse 8 257   Total cases notified 8 484  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.5 2.0 1.6
Age < 15 200 125 84
Laboratories 2012
Smear (per 100 000 population) 5.1
Culture (per 5 million population) 24.8
Drug susceptibility testing (per 5 million population) 0.5
Is second-line drug susceptibility testing available? Yes, outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 86   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 74  
Retreatment 73  
TB/HIV 2012 Number (%)
TB patients with known HIV status 5 049 (60)
HIV-positive TB patients 164 (3)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART) 164 (100)
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.2 (0.44–2.6) 11 (8.9–14)
MDR-TB cases among notified pulmonary
TB cases
74 (27–160) 75 (60–94)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 1 376 (22%) 634 (94%) 2 099
Laboratory-confirmed MDR-TB cases 32 71 117
Patients started on MDR-TB treatment     44
Financing TB control 2013
National TB programme budget (US$ millions)  
% Funded domestically  
% Funded internationally  
% Unfunded  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-20 Data: www.who.int/tb/data